|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
p399912 |
| 005 |
20240119171819.0 |
| 008 |
930716s1994 nyua b 001 0 eng |
| 010 |
|
|
|a 93005876
|o 28587230
|
| 019 |
|
|
|a 29395334
|
| 020 |
|
|
|a 0781701007
|
| 035 |
|
|
|9 ACO-1167
|
| 035 |
|
|
|a (OCoLC)28587230
|
| 040 |
|
|
|a DLC
|c DLC
|d CSZ
|d TMV
|d NLM
|d MPA
|d UtOrBLW
|
| 049 |
|
|
|a MPAR
|
| 050 |
0 |
0 |
|a HD9665.5
|b .S68 1993
|
| 082 |
0 |
0 |
|a 338.8/8716151
|2 20
|
| 099 |
|
|
|a HD
|a 9666.3
|a .S68
|a 1994
|
| 100 |
1 |
|
|a Spilker, Bert.
|0 n 84025421
|
| 245 |
1 |
0 |
|a Multinational pharmaceutical companies :
|b principles and practices /
|c Bert Spilker.
|
| 250 |
|
|
|a Second edition.
|
| 264 |
|
1 |
|a New York :
|b Raven Press,
|c [1994]
|
| 264 |
|
4 |
|c ©1994
|
| 300 |
|
|
|a xli, 803 pages :
|b illustrations ;
|c 29 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Rev. ed. of: Multinational drugs companies. c1989.
|
| 504 |
|
|
|a Includes bibliographical references (p. 779-782) and indexes.
|
| 505 |
0 |
|
|a Overview of a pharmaceutical company and the industry -- Pharmaceutical industry: definitions -- Big picture -- Standards -- Mergers, joint ventures and alliances -- Pharmacopolitics -- Institutional memory -- Keys for pharmaceutical success -- Corporate organization and management issues -- Models of international operations -- Organization at the corporate level -- Corporate management -- Enhancing communication -- Personnel issues -- Golden rules of staffing -- Conflicts of interest -- Crisis management -- Differences between pharmaceutical companies -- Future environments for medicine discovery and development -- Medicine discovery and development -- Overview of factors affecting medicine discovery -- Medicine discovery process -- Golden rules of medicine discovery -- Medicine development process -- Golden rules of medicine development -- Biotechnology -- Extrapolating animal safety data to humans -- Evaluating and interpreting data -- Stimulating innovation and increasing efficiency -- Future of medicine discovery.
|
| 505 |
0 |
|
|a (cont) Research and development organization and management issues -- Organizing research and development -- Managing research and development -- Personnel issues in medicine discovery and development -- Balancing line function and matrix approaches -- Choosing the number of medicines to develop -- Criteria for developing medicines -- Evaluating a portfolio of investigational medicine projects -- Productivity, innovation and project success -- Medical-marketing interface -- Corporate issues regarding the medical marketing interface -- Organizational and staffing issues regarding the madical marketing interface -- Medical and marketing needs, wants, possibilities and problems in developing new medicines -- Joint medical and marketing activities -- Technical and functional issues and activities -- Information technology -- Providing product information -- Data management and statistics -- Toxicology issues -- Clinical trials -- Issues of technical development -- Marketing issues -- Licensing issues -- Regulatory affairs -- Production issues -- Patent issues -- Legal activities and issues.
|
| 505 |
0 |
|
|a (cont) Financial issues -- Major corporate issues and challenges -- Animal testing and animal welfare -- Patient package inserts -- Patent expiration -- Switching prescription medicines to over the counter status -- Interaction with legislators and the public -- Costs and pricing -- International development -- External interactions and relationships -- Interactions and relationships with academic institutions -- Technology transfer from academia -- Interactions and relationships with government agencies -- Interactions and relationships between pharmaceutical companies: competition and collaboration -- Interactions and relationships with trade associations -- Interactions and relationships with health professionals -- Interactions and relationships with patients and the public -- Interactions and relationships with the media -- Selected books about medicine development or of particular interest to the pharmaceutical industry.
|
| 650 |
|
0 |
|a Pharmaceutical industry.
|0 sh 85039713
|
| 650 |
|
0 |
|a Pharmaceutical industry
|x Technological innovations.
|0 sh 85039715
|
| 650 |
|
0 |
|a Drugs
|x Research
|x Management.
|0 sh 85039745
|
| 650 |
|
0 |
|a International business enterprises.
|0 sh 85067372
|
| 650 |
|
7 |
|a Medication.
|2 homoit
|0 homoit0001007
|
| 650 |
|
7 |
|a Therapies.
|2 homoit
|0 homoit0001366
|
| 700 |
1 |
|
|a Spilker, Bert.
|t Multinational drugs companies.
|0 n 84025421
|
| 951 |
|
|
|a 399912
|
| 999 |
f |
f |
|i d4087583-3f49-52bb-b25b-04b5c06fe592
|s f97adbf8-d8b4-5910-add8-4a0423a8433b
|t 0
|
| 952 |
f |
f |
|p Can circulate
|a Massachusetts College of Pharmacy and Health Sciences
|b Boston Campus
|c MCPHS Boston Library
|d Boston Circulation
|t 0
|e HD9666.3 .S68 1994
|h Library of Congress classification
|i Book
|m 0113401274619
|
